Page last updated: 2024-09-04

san 32-468 and isoproterenol

san 32-468 has been researched along with isoproterenol in 1 studies

Compound Research Comparison

Studies
(san 32-468)
Trials
(san 32-468)
Recent Studies (post-2010)
(san 32-468)
Studies
(isoproterenol)
Trials
(isoproterenol)
Recent Studies (post-2010) (isoproterenol)
61030,7808032,640

Protein Interaction Comparison

ProteinTaxonomysan 32-468 (IC50)isoproterenol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.246
Beta-1 adrenergic receptorHomo sapiens (human)0.333
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)1.77
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-2 adrenergic receptorCanis lupus familiaris (dog)0.6667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nathanson, JA1

Other Studies

1 other study(ies) available for san 32-468 and isoproterenol

ArticleYear
Biochemical and physiological effects of S-32-468, a beta-adrenoceptor antagonist with possible oculoselectivity.
    Current eye research, 1985, Volume: 4, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Ciliary Body; Enzyme Activation; Humans; Intraocular Pressure; Isoproterenol; Lung; Male; Myocardium; Propanolamines; Rabbits; Timolol

1985